Labcorp SVP logs award, tax and share sale

Labcorp Holdings senior vice president and chief accounting officer Peter J. Wilkinson reported a mix of equity compensation and related share dispositions.

Rhea-AI Filing Summary

Labcorp Holdings senior vice president and chief accounting officer Peter J. Wilkinson reported a mix of equity compensation and related share dispositions. On March 26, 2026, he acquired 2,388 shares of common stock at $0.00 per share pursuant to a performance award covering the three-year period ended December 31, 2025. That same day, 755 shares were withheld at $268.38 per share to satisfy tax withholding obligations, leaving 3,485.2194 shares directly owned. On March 27, 2026, he executed an open-market sale of 1,633 shares at an average price of $267.05 per share under a pre-arranged Rule 10b5-1 trading plan, resulting in direct ownership of 1,852.2194 shares.

Insider Trade Summary 10b5-1

Net Seller: 1,633 shares

Net Sell 3 txns

Insider Wilkinson Peter J

Role SVP, Chief Accounting Officer

Sold 1,633 shs ($436K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,633	$267.05	$436K
Grant/Award	Common Stock	2,388	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	755	$268.38	$203K

Holdings After Transaction: Common Stock — 1,852.2194 shares (Direct)

Footnotes (3)

1. F1. Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.
2. F2. Stock withholding to satisfy tax withholding obligations.
3. F3. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Key Figures

Performance award shares: 2,388 shares Tax withholding shares: 755 shares Open-market sale: 1,633 shares at $267.05/share +3 more

6 metrics

Performance award shares 2,388 shares Common stock acquired at $0.00 on March 26, 2026

Tax withholding shares 755 shares Withheld at $268.38 per share on March 26, 2026

Open-market sale 1,633 shares at $267.05/share Common stock sold on March 27, 2026 under Rule 10b5-1 plan

Shares after tax withholding 3,485.2194 shares Direct ownership after March 26, 2026 transactions

Shares after sale 1,852.2194 shares Direct ownership following March 27, 2026 sale

Net sell shares 1,633 shares Net buy/sell shares from transaction summary

Key Terms

performance award, stock withholding, Rule 10b5-1, tax withholding obligations, +1 more

5 terms

performance award financial

"pursuant to a performance award granted on February 7, 2023, relating"

stock withholding financial

"Stock withholding to satisfy tax withholding obligations."

Rule 10b5-1 regulatory

"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

tax withholding obligations financial

"Stock withholding to satisfy tax withholding obligations."

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Labcorp (LH) executive Peter Wilkinson report in this Form 4?

Peter Wilkinson reported a performance-based share award, tax-related share withholding, and an open-market sale of Labcorp common stock. The filing shows both equity compensation and subsequent share dispositions tied to that award.

How many Labcorp (LH) shares did Peter Wilkinson receive as a performance award?

He acquired 2,388 shares of Labcorp common stock at $0.00 per share. The grant was pursuant to a performance award granted on February 7, 2023, based on results over the three-year period ended December 31, 2025.

How many Labcorp (LH) shares were sold and at what price in this Form 4?

Wilkinson sold 1,633 shares of Labcorp common stock at an average price of $267.05 per share. The filing states this was an open-market sale made under a pre-arranged Rule 10b5-1 trading plan.

Why were some Labcorp (LH) shares withheld in Peter Wilkinson’s Form 4?

The Form 4 shows 755 shares were withheld at $268.38 per share. A footnote explains this was stock withholding to satisfy tax withholding obligations associated with the equity grant rather than an open-market sale.

How many Labcorp (LH) shares does Peter Wilkinson hold after these transactions?

After the reported transactions, Wilkinson directly owns 1,852.2194 shares of Labcorp common stock. This figure reflects the performance award received, the shares withheld for taxes, and the subsequent open-market sale reported in the filing.

Was Peter Wilkinson’s Labcorp (LH) share sale pre-planned under Rule 10b5-1?

Yes. A footnote states the sale was made pursuant to a plan in accordance with Rule 10b5-1. Such plans are pre-arranged trading programs that schedule transactions in advance under the Securities Exchange Act of 1934.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/30/2026 - 12:54 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wilkinson Peter J

(Last) (First) (Middle)

231 MAPLE AVENUE

(Street)

BURLINGTON NORTH CAROLINA 27215

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/26/2026		A(1)		2,388	A	$0	4,240.2194	D
Common Stock	03/26/2026		F(2)		755	D	$268.38	3,485.2194	D
Common Stock	03/27/2026		S(3)		1,633	D	$267.05	1,852.2194	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.

2. Stock withholding to satisfy tax withholding obligations.

3. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Peter J. Wilkinson	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)